The effects of nigella sativa (Kalonji) on lipid profile in patients with stable coronary artery disease in Multan, Pakistan

Pakistan Journal of Nutrition

Volumn 10, Issue 2, 2011, Pages 162-167

  Tasawar, Zahida ^a   Siraj, Zeshan ^a   Ahmad, Nisar ^b   Lashari, Mushtaq H ^a  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b Ch Pervaiz Elahi Institute of Cardiology   (Pakistan)

Author keywords

Cholesterol; HDL; LDL; Nigella sativa; Statin; VLDL

Indexed keywords

HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAKISTAN; RECOMMENDED DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

NIGELLA; NIGELLA SATIVA;

EID: 79953666846     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2011.162.167     Document Type: Article

References (40)

1. Abdel-Aal, E.S.M. and R.S. Attia, 1993. Characterization of black cumin (Nigella sativa) seeds. Alex. Sci. Exch., 14: 483-496.
2. Al-Elyani, R.A.A., 2008. Protective effect of honey with Nigella sativa mixture and the ginger on the enoxaparin sodium (anticoagulant drug) hepatotoxicity of albino rats. Umm Al-Qura Uni. J. Sci. Med. Eng., 20: 39-48.
3. AN, B.A., A.O. Bamosa and Z.A. Al-Hawsawi, 2003. Effect of Nigella sativa on blood lipids in normal rats. Arab. Gulf. J. Sci. Res., 21: 102-109.
4. AN, B.H. and G. Blunden, 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res., 17: 299-305.
5. Babayan, V.K., D. Koottungal and G.A. Halaby, 1978. Proximate analysis, fatty acid and amino acid composition of Nigella sativa L. seeds. J. F. Sci., 43: 1315-1319.
6. Badary, O.A., A.B. Abdel-Naim, M.H. Abdel-Wahab and F.M. Hamada, 2000. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology, 143: 219-226.
7. Badary, O.A., R.A., Taha, A.M. Gamalel-Din and M.H. Abdel-Wahab, 2003. Thymoquinone is a potent superoxide anion scavenger. Drug. Chem. Toxicol., 26: 87-98.
8. Bamosa, A.O., B.A. AN and S.A. Sowayan, 1997. Effect of oral ingestion of Nigella sativa seed on some blood parameters. Saudi Pharm. J., 5: 126-129.
9. Bamosa, A.O., A.A. Basil and A.A. Zubaida, 2002. The effect of thymoquinone on blood lipids in rats. In. J. Pharmacol., 46: 195-201.
10. Baser, K.H.C., G. Honda and W. Miki, 1986. Herb drugs and herbalists in Turkey. Institute for the study of languages and cultures of Asia and Africa, Tokyo.
11. Dahri, A.H., 1996. Study of morphological changes in aorta and coronary arteries of albino rats fed on atherogenic diet with Nigella sativa and palm oil. (Thesis). Punjab University, pp: 123-130.
12. Deliorman, D., T. Calis, F. Ergun, B.S. Dogan, C.K. Buharalioghu and K. Kanzik, 2002. Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album. J. Ethnopharmacol., 72: 323-339.
13. El-Dakhakhani, M., 1982. Some pharmacological properties of some constituents of Nigella sativa seeds. Planta. Med., 1: 426-428.
14. El-Dakhakhani, M., N.L. Mady and M.A. Halim, 2000. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforschung, 50: 832-836.
15. El-Saleh, S.C., O.A. Al-Saqair and M.I. Al-Khalaf, 2004. Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomo-cysteinemia in rats. Int. J. Cardiol., 93: 19-23.
16. Feldman, E.B., 2001. Cardiovascular disease prevention by diet. Berdanier, CD. Eds. CRC Handbook of Nutrition and Foods CRC Press Boca Raton, FL.
17. Gad, A.M., M. El-Dakhakhny and M.M. Hassan, 1963. Studies on the chemical composition of Egyptian Nigella sativa L. oil. Planta. Medica., 11: 134-138.
18. Gilani, A.H., Q. Jabeen and M.A.U. Khan, 2004. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak. J. Biol. Sci., 7: 441-451.
19. Grundy, S.M., 1989. Monounsaturated fatty acids and cholesterol metabolism, implications for dietary recommendations. J. Nutr., 119: 529-533.
20. Handa, S.S., 1998. The integration of food and medicine in India. In: Prendergast, H.D.V., Etkin, N.L., Harris, D.R., Houghton, P.J. (Eds.), Plants for Food and Medicine. Royal Botanic Gardens, Kew, pp: 57-68.
21. Kanter, M., I. Meral and S. Dede, 2003. Effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and some liver enzymes in CCU-treated rats. J. Vet. Med. A Physiol. Pathol. Clin. Med., 50: 264-268.
22. Lamba, S.S., K.Y. Buch, H. Lewis and J. Lamba, 2000. Phytochemicals as potential hypoglycemic agents. Stud. Nat. Prod., 21: 457-496.
23. Le, P.M., A. Benhaddou-Andaloussi, A. Settaf, Y. Cherrah and P.S. Haddad, 2004. The petroleum ether extract of Nigella sativa exerts lipid lowering action in the rats. J. Ethanopharmacol., 94: 251-259.
24. Luc, G. and J.C. Fruchart, 1991. Oxidation of lipoproteins and atherosclerosis. Am. J. Clin. Nutr., 53: 206-209.
25. Mahfouz, M. and M. El-Dakhakhny, 1960. Some chemical and pharmacological properties of the new antiasthmatic drug, Nigellone. Egypt Pharm. Bull., 42: 411-424.
26. Malhotra, S.K., 2006. Nigella In: Peter, K.V. (Ed.), Handbook of Herbs and Spices, vol. 2. Woodhead Publishing Ltd., Cambridge, pp: 206-214.
27. Murray, M.T., 1995. The Healing power of herbs (2nd Edn.), Prima Publishing Murray MT and Pizzorno JE (1991). Atherosclerosis. In: Encyclopedia of Natural Medicine published by Prima Publishing, CA, pp: 156-170.
28. Najmi, A., M. Nasiruddin and R.A. Khan, 2008. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int. J. Diab. Dev. Ctries., 28: 11-14.
29. Nicholls, S.J., E.M. Tuzcu, I. Sipahi, A.W. Grasso, P. Schoenhagen, T. Hu, K. Wolski, T. Crowe, M.Y. Desai, S.L. Hazen, S.R. Kapadia and S.E. Nissen, 2007. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA., 297: 499-508.
30. Okazaki, S., T. Yokoyama and K. Miyauchi, 2004. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The establish study. Circulation, 110: 1061-1068.
31. Qidwai, W., H.B. Hamza and A. Gilani, 2009. Effectiveness, safety and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure and body weight in adults: Results of a randomized, double-blind controlled trial. J. Altern Complement Med., 15: 639-644.
32. Ramadan, M.F., 2007. Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L): An overview. Int. J. Food Sci. Tech., 42: 1208-1218.
33. Ridker, P.M., E. Danielson and F.A. Fonseca, 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med., 359: 2195-207.
34. Sacks, F.M., M.A Pfeffer and LA. Moye, 1996. The cholesterol and recurrent events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med., 335: 1001-1009.
35. Stamler, J., D. Wentworth and J.D. Neaton, 1986. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the multiple risk factor intervention trial (MRFIT). J. Am. Med. Assoc., 256: 2823-2828.
36. Tahir, K.E., M.M. Ashour and M.M. AlHarbi, 1993. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: Elucidation of the mechanism of action. Gen. Pharmacol., 24: 1123-1131.
37. Tissera, M.H.A., K.S. Kumaranayaka and P. Serasinghe, 1997. Effective reduction of Serum Cholesterol by Baraka Oil (Oil of Nigella Sativa) http://barakaoil.org/ reductioncholesterol.php. (Accessed: December 13, 2007). Available from: http://barakaoil.org/reduction cholesterol.php
38. Toppozada, H.H., H.A. Mazloum and M. El Dakhakhny, 1965. The antibacterial properties of the Nigella sativa I. Seeds. Active principle with some clinical applications. J. Egypt. Med. Assoc., 48 (Suppl-202).
39. Zaoui, A., Y. Cherrah, M.A. Lacaille-Dubois, A. Settaf, H. Amarouch and M. Hassar, 2000. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie, 55: 379-382.
40. Zaoui, A., Y. Cherrah, K. Alaoui, N. Mahassine, H. Amarouch and M. Hassar, 2002. Effects of Nigella sativa fixed oil on blood homeostasis in rats. Ethnopharmacology, 79: 23-26.